Enzo Biochem, Inc.
ENZ
Market Cap$60.45M
Close$
$-0.95
184.3% downside
Current Fair Value
184.3% downsideOvervalued by 184.3% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $60.45 Million |
|---|---|
| Enterprise Value | $3.66 Million |
| Dividend Yield | $0.0 (0.0%) |
| Earnings per Share | $0.65 |
| Beta | 0.06 |
| Outstanding Shares | 51,225,734 |
| Avg 30 Day Volume | 102,299 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | 1.86 |
|---|---|
| PEG | -2.54 |
| Price to Sales | - |
| Price to Book Ratio | 1.13 |
| Enterprise Value to Revenue | 0.29 |
| Enterprise Value to EBIT | -0.81 |
| Enterprise Value to Net Income | 0 |
| Total Debt to Enterprise | 0.94 |
| Debt to Equity | 0.05 |
Revenue Sources
No data
ESG Score
No data
About Enzo Biochem, Inc.
CEO: Elazar Rabbani